You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HNSCC

Showing 26 - 50 of 735
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

Completed
  • HNSCC
  • Head and Neck Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2022

HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)

Recruiting
  • HNSCC
  • +4 more
  • blood draws
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • NDURE
  • Charleston, South Carolina
    Medical University of South Carolina
May 25, 2022

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

HNSCC Trial in Chengdu (Radiotherapy)

Recruiting
  • HNSCC
  • Radiotherapy
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Apr 16, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • 3cycles (Toripalimab + cetuximab)
  • +2 more
  • Wuhan, Hebei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023

Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)

Active, not recruiting
  • Head and Neck Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jan 31, 2023

Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma, Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 21, 2022

HNSCC Trial in Houston (Bimiralisib)

Terminated
Has Results
  • HNSCC
  • Houston, Texas
    M.D. Anderson Cancer Center
Dec 22, 2021

Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinomas
  • Tislelizumab + Dasatinib + Quercetin
  • surgery
  • (no location specified)
Feb 2, 2023

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Penpulimab injection
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
    Oct 7, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Germany (Pembrolizumab, Lenvatinib)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Augsburg, BY, Germany
    • +7 more
    Jun 20, 2022

    Head and Neck Squamous Cell Cancer

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • OncoPrism-HNSCC™
    • San Francisco, California
      Curebase
    Sep 7, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Aurora, Colorado Springs, Highlands Ranch (Atezolizumab, Stereotactic Body

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Aurora, Colorado
    • +3 more
    Jun 15, 2022

    NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

    Not yet recruiting
    • NSCLC
    • +3 more
    • YL202 should be intravenously infused
    • Chang chun, Jilin, China
      Jilin Provincial Cancer Hospital
    Oct 25, 2023

    Head Neck Cancer Trial in Netherlands (PD-L1 imaging, Durvalumab)

    Completed
    • Head and Neck Cancer
    • Amsterdam, Netherlands
    • +3 more
    Jan 6, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Camrelizumab+cetuximab+chemo)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Shanghai, China
      Fudan University
    Jan 4, 2023

    Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Oral Cancer
    • Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
    • Guangzhou, Guangdong, China
      Sun yat-sun memorial hospital
    Jul 10, 2023

    HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

    Not yet recruiting
    • HPV-Related Squamous Cell Carcinoma
    • HNSCC
    • London, United Kingdom
      East and North Hertfordshire NHS Trust Mount Vernon Hospital
    Aug 24, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • dose-reduced radiotherapy
    • Zhuhai, Guangdong, China
      Fifth Affiliated Hospital of Sun Yat-sen University
    May 3, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Aug 23, 2022

    Circulating Tumor DNA Kinetics in Immuno-oncology

    Completed
    • Head and Neck Cancer
    • +4 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 16, 2022

      Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

      Withdrawn
      • Advanced Solid Tumor
      • +9 more
      • (no location specified)
      Oct 16, 2023